ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1518

Relationship Between Estimated Sodium and Potassium Intake with Blood Pressure and Inflammatory Markers in Patients with Rheumatoid Arthritis

Cecilia P. Chung1, Michelle J. Ormseth2, Annette M. Oeser3, Joseph F. Solus4, Chimalum Okafor5, Jens Titze5, Yahua Zhang5 and C. Michael Stein6, 1Medicine, Div of Rheumatology & Immunology, Vanderbilt University, Nashville, TN, 2Department of Medicine, Division of Rheumatology, Vanderbilt University, Nashville, TN, 3Vanderbilt University, Nashville, TN, 4Clinical Pharmacology, Vanderbilt University, Nashville, TN, 5Medicine, Vanderbilt University, Nashville, TN, 6Div of Clinical Pharmacology, Vanderbilt University, Nashville, TN

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: hypertension and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Hypertension is highly prevalent in patients with rheumatoid arthritis (RA). High sodium and low potassium intake are both modifiable determinants of blood pressure in the general population and can be estimated by measuring urinary sodium and potassium excretion. Moreover, a high sodium:potassium  ratio is associated with increased risk of high blood pressure. However, little is known about the relationship between sodium and potassium intake and blood pressure in patients with RA. Thus, we examined the hypothesis that sodium and potassium excretion is related to blood pressure and markers of inflammation in patients with RA.

Methods: We studied 166 patients with RA and 92 control subjects frequency-matched for age, sex, and race. First morning urine samples were collected and the concentrations of urine sodium and potassium were measured by flame photometry and 24 hour sodium and potassium excretion were estimated with the Kawasaki formula, a validated method that incorporates age, sex, height, weight, and urine creatinine. Blood pressure was the average of two resting measurements. In patients with RA, sedimentation rate and concentrations of vascular cell adhesion molecule-1, C-reactive protein, interleukin-6 and tumor necrosis factor were measured. Fisher’s exact and Wilcoxon’s tests were used to compare categorical and continuous variables, respectively. The associations between systolic (SBP), diastolic blood pressures (DBP), and inflammatory markers with estimated 24 hour urinary sodium, potassium, and sodium:potassium intake ratio were tested using Spearman correlations. For the blood pressure analyses, linear regressions were modeled to adjust for age, sex, and race.

Results: Patients with RA and control subjects had a similar mean age (54.2±11.9 vs. 53.2±11.6, p=0.43), were predominantly female (69% vs. 63%, p=0.41) and Caucasian (89% vs. 85%, p=0.44). Patients with RA had higher rates of hypertension (54% vs. 39%, p = 0.03). The estimated 24 hour sodium [median (interquartile range) of 5.1 (3.9-6.6) and 4.9 (4.0-6.5) g/day, respectively, p=0.90] and potassium [2.5 (2.1-3.2) and 2.7 (2.2-3.8) g/day, p=0.08] intake were similar in patients with RA and control subjects. The  urinary sodium:potassium ratio was higher in patients with RA than in controls [2.0 (1.6-2.4) and 1.7 (1.5-2.1), p=0.02] but was not associated with blood pressure in either group.  Lower potassium (g/day) intake was associated with DBP in patients with RA [β coefficient (95% CI) =-1.79, p=0.04], but there was no significant association between the estimated sodium or potassium intake or their ratio with markers of inflammation (all p>0.05).  

Conclusion: Patients with RA had significantly lower estimated sodium:potassium intake ratio than control subjects. Higher 24 hour potassium intake was significantly associated with lower DBP in patients with RA. Further studies are needed to evaluate the impact of diets with low sodium and high potassium content on blood pressure in patients with RA.

Grants: P60AR056116, K23AR064768, KL2TR000446, GM5M01-RR00095, UL1 RR024975-01, and 2 UL1 TR000445-06 from the NIH, and a grant from Alpha Omicron Pi


Disclosure: C. P. Chung, NIH, 2; M. J. Ormseth, None; A. M. Oeser, None; J. F. Solus, None; C. Okafor, None; J. Titze, None; Y. Zhang, None; C. M. Stein, None.

To cite this abstract in AMA style:

Chung CP, Ormseth MJ, Oeser AM, Solus JF, Okafor C, Titze J, Zhang Y, Stein CM. Relationship Between Estimated Sodium and Potassium Intake with Blood Pressure and Inflammatory Markers in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/relationship-between-estimated-sodium-and-potassium-intake-with-blood-pressure-and-inflammatory-markers-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relationship-between-estimated-sodium-and-potassium-intake-with-blood-pressure-and-inflammatory-markers-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology